Trending Topic

14 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked
Isabella Henderson, Nisali A Gunawardane, Ruben I Kuzniecky

Epilepsy affects approximately 1% of the global population, with one-third of patients remaining refractory to medical therapy.1 Drug-resistant epilepsy (DRE), defined as the failure of two appropriately chosen antiseizure medications (ASMs) to achieve seizure freedom, poses significant risks, including injury and sudden unexpected death in epilepsy (SUDEP).2 Early identification of DRE is critical to enable timely exploration […]

Aksel Siva, AAN 2019 – Diagnosis and treatment of neuro-Behçet disease (Part 2)

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: May 29th 2019

US Neurology Editorial Board member, Aksel Siva (Istanbul University, Cerrahpaşa School of Medicine, Istanbul, Turkey), discusses latest initiatives in the diagnosis of neuro-Behçet disease, a rare and relatively unknown neurological disorder, as well as promising investigational therapies.

 

Questions

  1. How can MRI imaging parameters be used in the differential diagnosis of neuro-Behçet disease and other central nervous system inflammatory disorders? (0:04)
  2. What are the limitations of current treatment options for neuro-Behçet disease? (3:17)
  3. What investigational therapies appear most promising? (5:39)

 

View Part 1 of this expert interview here.

 

Speaker disclosures: Aksel Siva has nothing to disclose in relation to this video interview.

 

Filmed at the American Academy of Neurology (AAN) Annual Meeting, Philadelphia, USA, May 2019.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup